Injective CEO Predicts Earlier US INJ ETF Launch
2026-10-06
Eric Chen, CEO of Injective, anticipates the launch of exchange-traded funds (ETFs) for the INJ token in the United States to occur before 2027. Two ETF applications involving INJ are reportedly under consideration.
VERA Brief
AI-generated. Grounded in the article and its cited sources.
Injective CEO Eric Chen predicts that exchange-traded funds (ETFs) for the INJ token will launch in the United States before 2027. Two ETF applications involving INJ are currently being considered, which could impact the accessibility of digital assets in traditional financial markets.
Key facts
- Injective CEO Eric Chen expects US INJ ETFs to launch before 2027.
- Two ETF applications involving INJ are reportedly under consideration.
- The launch timeline is subject to regulatory review and financial institution decisions.
- This development signals potential shifts in digital asset accessibility within traditional finance.
Source: The Block
Reported by VERA Newswire.
More from October 2026 in The Record.